MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).
| Outcome | beta | se | p | method | nSNP | cis/trans | coloc |
|---|---|---|---|---|---|---|---|
| Non-cancer illness code self-reported: uterine fibroids | -0.398 | 0.0686 | 6.85e-09 | Wald ratio | 1 | cis | 0.99 |
| Diagnoses - main ICD10: D25 Leiomyoma of uterus | -0.37 | 0.073 | 3.90e-07 | Wald ratio | 1 | cis | NA |
| ER-negative Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) | 0.152 | 0.0322 | 2.29e-06 | Wald ratio | 1 | cis | NA |
| Cancer code self-reported: prostate cancer | -0.303 | 0.0908 | 8.50e-04 | Wald ratio | 1 | cis | NA |
| Non-cancer illness code self-reported: chronic obstructive airways disease or copd | 0.25 | 0.0762 | 0.00104 | Wald ratio | 1 | cis | NA |
| Primary sclerosing cholangitis | -0.235 | 0.0792 | 0.00297 | Wald ratio | 1 | cis | NA |
| Non-cancer illness code self-reported: hiatus hernia | 0.0956 | 0.0339 | 0.0048 | Wald ratio | 1 | cis | NA |
| Diastolic blood pressure automated reading | -0.0163 | 0.00579 | 0.00493 | Wald ratio | 1 | cis | NA |
| Diagnoses - main ICD10: D12 Benign neoplasm of colon rectum anus and anal canal | -0.153 | 0.0561 | 0.00633 | Wald ratio | 1 | cis | NA |
| Diagnoses - main ICD10: C61 Malignant neoplasm of prostate | -0.237 | 0.0891 | 0.00782 | Wald ratio | 1 | cis | NA |
| Cancer code self-reported: malignant melanoma | -0.199 | 0.0792 | 0.0119 | Wald ratio | 1 | cis | NA |
| High grade serous ovarian cancer | 0.0976 | 0.0407 | 0.0166 | Wald ratio | 1 | cis | NA |
| …and 75 more outcomes (see JSON) |
No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).
No GWAS Catalog associations mapped to this gene.
Top diseases by Open Targets association (of 93 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.
| Disease | genetic assoc. | burden (ExWAS) | causal status | MR status |
|---|---|---|---|---|
| Abnormality of the skeletal system | 0.867 | — | common-variant locus | no MR -> candidate analysis |
| prostate carcinoma | 0.818 | — | common-variant locus | no MR -> candidate analysis |
| uterine corpus leiomyoma | 0.81 | — | common-variant locus | no MR -> candidate analysis |
| Uterine leiomyoma | 0.723 | — | common-variant locus | no MR -> candidate analysis |
| clonal hematopoiesis | 0.662 | — | common-variant locus | no MR -> candidate analysis |
| renal carcinoma | 0.644 | — | common-variant locus | no MR -> candidate analysis |
| benign colon neoplasm | 0.58 | — | common-variant locus | MR: beta=-0.153, p=0.00633 (cis) |
| cancer | 0.563 | — | common-variant locus | MR: beta=-0.398, p=6.85e-09 (cis) |
| renal cell carcinoma | 0.565 | — | common-variant locus | no MR -> candidate analysis |
| clear cell renal carcinoma | 0.568 | — | common-variant locus | no MR -> candidate analysis |
| prostate cancer | 0.538 | — | common-variant locus | MR: beta=-0.303, p=8.50e-04 (cis) |
| estrogen-receptor negative breast cancer | 0.487 | — | common-variant locus | no MR -> candidate analysis |
| hematopoietic and lymphoid cell neoplasm | 0.482 | — | common-variant locus | no MR -> candidate analysis |
| uterine benign neoplasm | 0.411 | — | common-variant locus | no MR -> candidate analysis |
| breast carcinoma | 0.373 | — | common-variant locus | no MR -> candidate analysis |
Of the 15 rows above, 12 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.
| Layer | Result |
|---|---|
| ChEMBL druggability | not available — no ChEMBL target (undrugged) |
| gnomAD constraint | not available |
| GWAS Catalog | no mapped SNPs |
| ClinVar | no records |
| PharmGKB/ClinPGx | no annotations |
phenome — Top 30 of 93 associated diseases by overall score. genetic_association aggregates GWAS common-variant AND rare-variant evidence. These are ASSOCIATIONS (loci), not causal claims.chembl — No ChEMBL target for ‘KDELC2’.gnomad — No gnomAD constraint data.gwas — No GWAS Catalog SNPs mapped to this gene.clinvar — No ClinVar records.pharmgkb — No PharmGKB/ClinPGx clinical annotations (gene may not be a pharmacogene).gwas_traits — No GWAS Catalog associations mapped to this gene.uniprot: https://www.uniprot.org/uniprotkb/Q7Z4H8 — UniProt release 2026_02 (10-June-2026)mr_outcomes: https://epigraphdb.org/pqtl/ — EpiGraphDB pQTL MR (Zheng et al., Nat Genet 2020) — pre-computed two-sample MR; retrieved, not computed by this agent; EpiGraphDB build 1.0, pQTL dataset v3.0phenome: https://platform.opentargets.org/target/ENSG00000178202/associations — Open Targets data release 26.06